3D organ-on-a-chip: The convergence of microphysiological systems and organoids
Open accessThe DOI matches its Crossref record; 107 of the 107 references it cites were found in a registry or an index.
Abstract
Medicine today faces the combined challenge of an increasing number of untreatable diseases and fewer drugs reaching the clinic. While pharmaceutical companies have increased the number of drugs in early development and entering phase I of clinical trials, fewer actually successfully pass phase III and launch into the market. In fact, only 1 out of every 9 drugs entering phase I will launch. In vitro preclinical tests are used to predict earlier and better the potential of new drugs and thus avoid expensive clinical trial phases. The most recent developments favor 3D cell culture and human stem cell biology. These 3D humanized models known as organoids better mimic the 3D tissue architecture and physiological cell behavior of healthy and disease models, but face critical issues in production such as small-scale batches, greater costs (when compared to monolayer cultures) and reproducibility. To become the gold standard and most relevant biological model for drug discovery and development, organoid technology needs to integrate biological culture processes with advanced microtechnologies, such as microphysiological systems based on microfluidics technology. Microphysiological systems, known as organ-on-a-chip, mimic physiological conditions better than conventional cell culture models since they can emulate perfusion, mechanical and other parameters crucial for tissue and organ physiology. In addition, they reduce labor cost and human error by supporting automated operation and reduce reagent use in miniaturized culture systems. There is thus a clear advantage in combining organoid culture with microsystems for drug development. The main objective of this review is to address the recent advances in organoids and microphysiological systems highlighting crucial technologies for reaching a synergistic strategy, including bioprinting.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“To date, MPS models have been developed for the majority of human tissues and organs, and have also been established to study a diverse range of malignancies, including cancer (Baptista et al., 2022; Hachey et al. (2021; 2024); Jiang et al., 2024; Haque et al., 2022; Shen et al., 2023; Flont et al., 2023; Straehla et al., 2022).”
From Microphysiological systems as models for immunologically ‘cold’ tumors (2024) · cites this paper as Baptista et al., 2022
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche
Sato, T., Vries, R. G., Snippert, H. J., van de Wetering, M., Barker, N., Stange, D. E., van Es, J. H., Abo, A., Kujala, P., Peters, P. J., et al. (2009) · Nature · doi:10.1038/nature07935 · Cited by 7,204 · cited 1×
“Using adult stem cells (lgr5 positive cells) from the human intestine biopsy seeded on matrigel, these stem cells are capable of anchoring on extracellular matrix components of matrigel mimicking the epithelial polarity of intestine without a mesenchymal niche (Sato et al., 2009).”
BackgroundCerebral organoids model human brain development and microcephaly
Lancaster, M. A., Renner, M., Martin, C.-A., Wenzel, D., Bicknell, L. S., Hurles, M. E., Homfray, T., Penninger, J. M., Jackson, A. P., & Knoblich, J. A. (2013) · Nature · doi:10.1038/nature12517 · Cited by 5,372 · cited 1×
“This organoid recapitulates human cortical development in healthy and disease states (Lancaster et al., 2013).”
BackgroundReconstituting organ-level lung functions on a chip
Huh, D., Matthews, B. D., Mammoto, A., Montoya-Zavala, M., Hsin, H. Y., & Ingber, D. E. (2010) · Science · doi:10.1126/science.1188302 · Cited by 4,250 · cited 1×
“The device was capable of simulating breathing-type movements and responding to pathogen stimulus (Huh et al., 2010).”
BackgroundEngineering Flows in Small Devices: Microfluidics Toward a Lab-on-a-Chip
Stone, H. A., Stroock, A. D., & Ajdari, A. (2004) · Annual Review of Fluid Mechanics · doi:10.1146/annurev.fluid.36.050802.122124 · Cited by 3,666 · cited 1×
“the microchannels mimic the pressures exerted by vascularization, required for cell differentiation (Stone et al., 2004).”
BackgroundHow to improve R&D productivity: the pharmaceutical industry's grand challenge
Paul, S. M., Mytelka, D. S., Dunwiddie, C. T., Persinger, C. C., Munos, B. H., Lindborg, S. R., & Schacht, A. L. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3078 · Cited by 3,566 · cited 1×
“, 94% of drugs fail in the clinical trial phases (Paul et al., 2010; Scannell et al., 2012), leading to unsustainable costs in the healthcare system and drugs with low efficacy and safety to the population.”
BackgroundModeling Development and Disease with Organoids
Clevers, H. (2016) · Cell · doi:10.1016/j.cell.2016.05.082 · Cited by 3,196 · cited 1×
“Organoids can better predict ef fi cacy and safety, improving the quality of preclinical tests before human clinical trials (Clevers, 2016).”
BackgroundHuman organoids: model systems for human biology and medicine
Kim, J., Koo, B.-K., & Knoblich, J. A. (2020) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-020-0259-3 · Cited by 2,187 · cited 1×
“3D cell culture models, more specifically, organoids, can recreate human 3D tissue architecture and spatially and temporally recapitulate morphogenetic events due to human stem cell differentiation (Kim et al., 2020) while animal models are not predictable models for several human diseases and physiological responses,…”
BackgroundConcordance of the toxicity of pharmaceuticals in humans and in animals
Olson, H., Betton, G., Robinson, D., Thomas, K., Monro, A., Kolaja, G., Lilly, P., Sanders, J., Sipes, G., Bracken, W., et al. (2000) · Regulatory Toxicology and Pharmacology · doi:10.1006/rtph.2000.1399 · Cited by 2,050 · cited 1×
“An analysis of hundreds of drugs that failed in the later stage of drug development found that the preliminary assays conducted in rats and dogs were only able to predict human toxicity in 71% of cases (Olson et al., 2000).”
BackgroundDiagnosing the decline in pharmaceutical R&D efficiency
Scannell, J. W., Blanckley, A., Boldon, H., & Warrington, B. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3681 · Cited by 1,981 · cited 2×
“To reach approval, the novel drug must show safety and effectiveness in humans (Scannell et al., 2012).”
BackgroundDrost, J., & Clevers, H. (2018) · Nature Reviews Cancer · doi:10.1038/s41568-018-0007-6 · Cited by 1,790 · cited 1×
“Using iPS derived cells from patients or even primary cells from intestine or tumor biopsies, it is possible to recapitulate the disease development and genetic signatures from the disease of origin (Drost and Clevers, 2018).”
Background
Cited by
Type 1 Diabetes Mellitus: A Review on Advances and Challenges in Creating Insulin Producing Devices
Oliveira, S. M. R., Rebocho, A., Ahmadpour, E., Nissapatorn, V., & Pereira, M. D. L. (2023) · Micromachines · doi:10.3390/mi14010151 · Cited by 103
“Moreover, an organoid-on-a-chip technology is also currently being considered, particularly for bioprinting and drug development [90].”
BackgroundLi, B., Tang, Y., Huang, Z., Ma, L., Song, J., & Xue, L. (2025) · Protein & Cell · doi:10.1093/procel/pwaf058 · Cited by 57
“Organoid-on-a-chip represent a next-generation biological model that combines the self-organizing properties of organoids with the engineering precision of organ-on-a-chip systems (Baptista et al., 2022).”
Imaging 3D cell cultures with optical microscopy
Hsieh, H.-C., Han, Q., Brenes, D., Bishop, K. W., Wang, R., Wang, Y., Poudel, C., Glaser, A. K., Freedman, B., Vaughan, J. C., et al. (2025) · Nature Methods · doi:10.1038/s41592-025-02647-w · Cited by 49
Opportunities and challenges to engineer 3D models of tumor-adaptive immune interactions
Visalakshan, R. M., Lowrey, M. K., Sousa, M. G. C., Helms, H. R., Samiea, A., Schutt, C. E., Moreau, J. M., & Bertassoni, L. E. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1162905 · Cited by 35
Strategies for craniofacial tissue engineering: innovations for scalable bone regeneration
Vignolo, S. M., Roth, D. M., Wu, L., Cosgrove, J., & Bertassoni, L. E. (2025) · Plastic and Aesthetic Research · doi:10.20517/2347-9264.2025.09 · Cited by 76
Microfluidic-based human prostate-cancer-on-chip
Jiang, L., Khawaja, H., Tahsin, S., Clarkson, T. A., Miranti, C. K., & Zohar, Y. (2024) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2024.1302223 · Cited by 26
Alnasser, S. M. (2025) · Stem Cell Research & Therapy · doi:10.1186/s13287-025-04264-y · Cited by 33
Insights from herb interactions studies: a foundational report for integrative medicine
Gamil, N. M., Elsayed, H. A., Hamed, R. M., Salah, E. T., Ahmed, A. M., Mostafa, H. A., El‐Shiekh, R. A., & Abou-Hussein, D. (2025) · Future Journal of Pharmaceutical Sciences · doi:10.1186/s43094-025-00794-7 · Cited by 38
Microfluidic systems for modeling digestive cancer: a review of recent progress
Razavi, Z., Soltani, M., Pazoki-Toroudi, H., & Dabagh, M. (2024) · Biomedical Physics & Engineering Express · doi:10.1088/2057-1976/ad6f15 · Cited by 24
Kim, J. J., Bae, M., & Cho, D. (2024) · Small Science · doi:10.1002/smsc.202400314 · Cited by 29
Artificial Intelligence Virtual Organoids (AIVOs)
Bai, L., & Su, J. (2025) · Bioactive Materials · doi:10.1016/j.bioactmat.2025.12.030 · Cited by 65
“…status and spatial structure of organs under different drug, doses and culture conditions to train the initial virtual organ model, and then test the drug response, phenotypic transformation or long-term stability predicted by the model in independent organ-like experiments [143,144].”
Cancer-on-chip: a breakthrough organ-on-a-chip technology in cancer cell modeling
Nejati, B., Shahhosseini, R., Hajiabbasi, M., Ardabili, N. S., Baktash, K. B., Alivirdiloo, V., Moradi, S., Rad, M. F., Rahimi, F., Farani, M. R., et al. (2024) · Medical & Biological Engineering & Computing · doi:10.1007/s11517-024-03199-5 · Cited by 31
“However, tumor chips still encounter numerous obstacles before they can be widely utilized in practical pharmaceutical industrial and clinical applications, mainly due to the intricate physiological structure and microenvironment in vivo [71, 72].”
Bioethical implications of organ‐on‐a‐chip on modernizing drug development
Thakar, R. G., & Fenton, K. N. (2023) · Artificial Organs · doi:10.1111/aor.14620 · Cited by 27
da Silva, G. G., Sacomani, D. P., de Carvalho, B. G., Porcionatto, M. A., Gobbi, Â. L., Lima, R. S., & de la Torre, L. G. (2025) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.4c02221 · Cited by 26
Madan, A., Saini, R., Dhiman, N., Juan, S., & Satapathy, M. K. (2025) · Organoids · doi:10.3390/organoids4040023 · Cited by 24
Advances in organoid-on-a-chip for recapitulation of human physiological events
Park, B. J., Park, J., Han, S., Kwon, T., Sung, J. Y., Kim, J., Safarkhani, M., Min, K.-H., Lee, E.-H., Kang, S., et al. (2025) · Materials Today · doi:10.1016/j.mattod.2025.02.002 · Cited by 23
A Microfluidic Organ-On-A-Chip: Into the Next Decade of Bone Tissue Engineering Applied in Dentistry
Syahruddin, M. H., Anggraeni, R., & Ana, I. D. (2023) · Future Science OA · doi:10.2144/fsoa-2023-0061 · Cited by 20
Chan, W. S., Mo, X.-T., Ip, P. P. C., & Tse, K. Y. (2023) · Cancer Medicine · doi:10.1002/cam4.6521 · Cited by 23
“65 And as these culture techniques are not very common, the optimization of growth factors is also time-consuming and challenging.”
BackgroundInfluentialFrom cells to organs: progress and potential in cartilaginous organoids research
Wang, X., Liu, N., Zhang, H., Yin, Z., & Zha, Z.-G. (2023) · Journal of Translational Medicine · doi:10.1186/s12967-023-04591-9 · Cited by 22
“The combination of organoid culture with microfluidic technologies offers several advantages [143].”
BackgroundGaebler, D., Hachey, S. J., & Hughes, C. C. W. (2024) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2024.1462293 · Cited by 22
3D topographies promote macrophage M2d-Subset differentiation
Carrara, S. C., Dávila-Lezama, A., Cabriel, C., Berenschot, E., Krol, S., Gardeniers, H. J. G. E., Izeddin, I., Kolmar, H., & Susarrey‐Arce, A. (2023) · Materials Today Bio · doi:10.1016/j.mtbio.2023.100897 · Cited by 19
“To close this gap, novel cellular systems are gaining attraction, such as 3D cultures [2,3] or organ-on-a-chip technology that brings higher physiological relevance [4].”
BackgroundThe challenge of making the right choice: patient avatars in the era of cancer immunotherapies
Kayser, C., Bräuer, A., Susanne, S., & Wandmacher, A. M. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1237565 · Cited by 17
Advances and applications of organ-on-a-chip technology
Kong, J. S., Kim, J., Jang, J., & Cho, D.-W. (2026) · Cell Reports Methods · doi:10.1016/j.crmeth.2026.101361 · Cited by 20
Ardila, C. M., Jiménez‐Arbeláez, G. A., & Vivares‐Builes, A. M. (2023) · Dentistry Journal · doi:10.3390/dj11070158 · Cited by 19
Komarnisky, R.-M., Wootten, S., Friedman, N., & Nikkhah, M. (2025) · Lab on a Chip · doi:10.1039/d5lc00426h · Cited by 17
Advanced Biomanufacturing Technologies for Micro-physiological Systems
Kim, M. K., Yoon, J., Kim, D., Kim, J., Kim, J.-S., Go, G., Song, J., Son, S., Park, K., Lee, J., et al. (2025) · International Journal of Precision Engineering and Manufacturing · doi:10.1007/s12541-025-01330-6 · Cited by 16
Baptista, L. S., Silva, K. R., Jobeili, L., Guillot, L., & Sigaudo‐Roussel, D. (2023) · Cells · doi:10.3390/cells12121583 · Cited by 21
Emerging microfluidics for the modeling and treatment of arthritis
Yang, N., Sun, C., Dong, C., Huang, Y., Zhu, Y., & Gu, Z. (2024) · Engineered Regeneration · doi:10.1016/j.engreg.2024.02.002 · Cited by 14
Microphysiological systems as models for immunologically ‘cold’ tumors
Gaebler, D., Hachey, S. J., & Hughes, C. C. W. (2024) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2024.1389012 · Cited by 14
Bao, W., Liu, J., Du, C., Liu, S., Liu, J., Zhu, Z., Zhou, L., Li, Z. A., Huang, W., & Lei, Y. (2025) · Materials Today Bio · doi:10.1016/j.mtbio.2025.102222 · Cited by 28
“Therefore, the development of skeletal muscle-on-a-chip (SMoC) models provides a new platform for studying the structure and function of skeletal muscles and opens new avenues for research on skeletal muscle disorders and personalized treatments [7].”
Wan, Y., Ding, J., Jia, Z., Hong, Y., Tian, G., Zheng, S., Pan, P., Wang, J., & Liang, H. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e32965 · Cited by 13
Exploration of organoids in ovarian cancer: From basic research to clinical translation
Li, S., Lei, N., Chen, M., Guo, R., Han, L., Qiu, L., Wu, F., Jiang, S., Tong, N., Wang, K., et al. (2024) · Translational Oncology · doi:10.1016/j.tranon.2024.102130 · Cited by 13
Advanced polymeric systems for colon drug delivery: from experimental models to market applications
Crispino, R., Lagreca, E., Procopio, A., D’Auria, R., Corrado, B., Manna, S. L., Onesto, V., & Natale, C. D. (2025) · Soft Matter · doi:10.1039/d4sm01222d · Cited by 16
Gong, D., Mo, J., Zhai, M., Zhou, F., Wang, G., Ma, S., Dai, X., & Deng, X. (2025) · Frontiers in Medicine · doi:10.3389/fmed.2024.1521851 · Cited by 15
“By incorporating microfluidic technology, these chips enable the construction of more precise and controllable organoid models that simulate the microenvironment, vascularization, and tissue interactions (95).”
Salvadori, A., Watanabe, M., Marković, M., Sudo, R., & Ovsianikov, A. (2025) · Biofabrication · doi:10.1088/1758-5090/add37e · Cited by 16
“…features within OoC, overcoming the complexities associated with embedding a vascular network that guarantees physiological tissue perfusion continues to be a focal point in research, as it holds the key to enhancing the functionality and the applicability of these engineered platforms [7, 8].”
Hypoxia and Multilineage Communication in 3D Organoids for Human Disease Modeling
Ehab, S., Gaser, O. A., & Dayem, A. A. (2025) · Biomimetics · doi:10.3390/biomimetics10090624 · Cited by 13
“The ongoing progress in biotechnology and tissue engineering has led to the development of advanced 3D organoid systems, including multilineage organoids, assembloids, and organoids-on-a-chip, that more accurately replicate the architecture and function of human tissues [15,16].”
Yang, Y., Yang, H., Kiskin, F. N., & Zhang, J. Z. (2024) · Medical Review · doi:10.1515/mr-2023-0059 · Cited by 12
“Advancements in organoid-on-a-chip technology could largely reduce the cost and duration of drug discovery [51].”
BackgroundZhang, H., Li, L., Sun, X., Hou, B., & Luo, C. (2024) · Biomedical Microdevices · doi:10.1007/s10544-024-00715-0 · Cited by 9
“Tissue engineering and micromanufacturing technologies have made human organ chip models important in bio-medicine (Baptista et al. 2022).”
Advances and Applications of Micro- and Mesofluidic Systems
Alves, L. A. O., Félix, J. H. D. S., Ferreira, A. N. S., dos Santos, M. T. B., da Silva, C. G., de Castro, L. M. S., & dos Santos, J. C. S. (2025) · ACS Omega · doi:10.1021/acsomega.4c10999 · Cited by 9
Pancreatic Cancer Organoids: Modeling Disease and Guiding Therapy
Morceau, F., El‐Khoury, V., Lee, K., Berna, M. J., & Kwon, Y. (2025) · Cancers · doi:10.3390/cancers17233850 · Cited by 12
Stem cell niches functionalized strategies for organ regeneration and manufacturing
Liu, H., Hu, L., Zhang, D., Wang, X., & Wang, S. (2023) · The Innovation Medicine · doi:10.59717/j.xinn-med.2023.100037 · Cited by 9
Santoni, M., Piccinini, G., Liguori, G., Randi, M. R., Baroncini, M., Milani, L., & Danesi, F. (2025) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2024.1529027 · Cited by 10
Song, C., Yang, J., & Gu, Z. (2025) · Ageing Research Reviews · doi:10.1016/j.arr.2025.102728 · Cited by 8
Shariff, S., Kantawala, B., Franco, W. X. G., Ayele, N. D., Munyangaju, I., Alzain, F. E., Nazir, A., Wojtara, M., & Uwishema, O. (2024) · Annals of Medicine and Surgery · doi:10.1097/ms9.0000000000002078 · Cited by 9
“Patient sourcing is bene fi cial in terms of precision medicine and rare diseases but may introduce epigenetic pro fi ling, potentially affecting the result ’ s generality [18,76] .”
BackgroundOlawade, D. B., Odetayo, A., Egbon, E., Olasilola, R., Makanjuola, B. D., & Daniel, R. I. A. (2026) · Transplantation Reviews · doi:10.1016/j.trre.2026.101004 · Cited by 10
Advancements in Kidney-on-Chip: Antibiotic-Induced Kidney Injury and Future Directions
Kim, M., Lee, Y., Seo, G. M., & Park, S. (2024) · BioChip Journal · doi:10.1007/s13206-024-00160-4 · Cited by 7
Sharipol, A., & Frisch, B. J. (2024) · Frontiers in Hematology · doi:10.3389/frhem.2024.1407698 · Cited by 8
Yap, J. H., Zhang, H., Okamura, Y., & Kimura, H. (2024) · Materialia · doi:10.1016/j.mtla.2024.102247 · Cited by 6
Harnessing CRISPR technology for next-generation microphysiological systems
Song, S., Kang, H. W., Kang, M., Chung, S. H., Choi, N., Kim, H. N., & Sung, Y. J. (2025) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2025.118164 · Cited by 6
Amend, N., Koller, M., Schmitt, C., Worek, F., & Wille, T. (2023) · Toxicology Letters · doi:10.1016/j.toxlet.2023.10.007 · Cited by 8
Wang, Y., Chen, H., Zhang, Z., He, Y., Ji, L., Zhao, B., Wang, Q., Xu, J., Mao, S., Zhang, W., et al. (2024) · Biomedicines · doi:10.3390/biomedicines12122708 · Cited by 5
“The combination of these two technologies can help to overcome their individual limitations while simultaneously enhancing their advantages [41].”
Aggarwal, S., Chakraborty, A., Singh, V. K., Lory, S., Karalis, K., & Rahme, L. G. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1592597 · Cited by 6
“Microphysiological system leveraging technologies for organ on-chip engineering have emerged in the last few years (35 – 37).”
Advances and applications of organoid-on-a-chip in disease modeling
Yang, Y., Sheng, J., Sheng, F., Liang, X., Ma, C., Chen, R., Wang, S., & Qian, X. (2025) · The Analyst · doi:10.1039/d5an00514k · Cited by 8
Xia, Y., Xie, S., Cai, Z., & Shan, X. (2025) · Holistic Integrative Oncology · doi:10.1007/s44178-024-00104-w · Cited by 7
“It preset the biochemical signals, mechanical forces, nutrient supply, and other aspects of the culture environment of orga-noid models to construct different PDOs for further drug screening tests or mechanism studies [41, 42].”
Wang, X., Lin, D., & Feng, N. (2025) · World Journal of Surgical Oncology · doi:10.1186/s12957-025-03948-2 · Cited by 7
“Organoids-on-a-chip (OOC) systems, which integrate microfluidic technology with biological culturing meth-ods, have greatly enhanced the study of organ functions and tumor behavior [39].”
An Exploration of Organoid Technology: Present Advancements, Applications, and Obstacles
Mishra, I., Gupta, K., Mishra, R., Chaudhary, K., & Sharma, V. (2023) · Current Pharmaceutical Biotechnology · doi:10.2174/0113892010273024230925075231 · Cited by 7
Xiu, Z., Yang, Q., Xie, F., Han, F., He, W., & Liao, W. (2024) · Journal of Tissue Engineering · doi:10.1177/20417314241255470 · Cited by 6
Ghosh, P. (2024) · MGM Journal of Medical Sciences · doi:10.4103/mgmj.mgmj_96_24 · Cited by 5
Gastric Organoid, a Promising Modeling for Gastric Stem Cell Homeostasis and Therapeutic Application
Lee, S., Choi, J.-H., Park, S., & Kim, J. (2024) · International Journal of Stem Cells · doi:10.15283/ijsc23075 · Cited by 5
“However, organoid-on-a-chip is in emerging stage, so it still have technical limitations such as designing a new microfluidic devices (27).”
Modelling Cardiovascular Diseases Using Human Microphysiological Systems
Ribeiro, Q., Lopes, E., Ferreira, I. S., Simões, C. G., Vital, C. M., Inácio, J. M., Belo, J. A., Rybak‐Wolf, A., Marques, A. R. A., & Vieira, O. V. (2026) · BioChip Journal · doi:10.1007/s13206-025-00247-6 · Cited by 5
“…of multiple organ region–specific organoids or spheroids (“assem - bloids”) [339], and the combination of spheroids/organoids with microfluidics (“spheroid/organoid-on-a-chip”) [ 103, 142, 143, 338], are other strategies also being explored to these methods have demonstrated to be cell destructive.”
Tumor organoid and tumor-on-a-chip equipped next generation precision medicine
Zhao, W., Zhang, Z., Xu, S., Sun, X., Wang, Y., Ye, J., Wang, X., Gu, Z., & Chen, Z. (2025) · Biofabrication · doi:10.1088/1758-5090/ae0bb3 · Cited by 4
“The low diffusion efficiency of nutrients, coupled with the rapid decline in the concentration of growth factors in the culture medium, necessitates regular replenishment [158].”
Tárnoki-Zách, J., Boldizsár, I., Kovács, G. M., Döme, B., Bősze, S. E., & Czirók, A. (2025) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2025.107323 · Cited by 3
Chen, F., Wang, L., Liu, H., Wang, Y., Tang, B., & Bao, N. (2026) · Materials Today Bio · doi:10.1016/j.mtbio.2026.102822 · Cited by 5
Patel, G., & Amin, H. (2026) · Stem Cell Reviews and Reports · doi:10.1007/s12015-026-11096-7 · Cited by 2
How single-cell transcriptomics provides insight on hepatic responses to TCDD
Nault, R. (2023) · Current Opinion in Toxicology · doi:10.1016/j.cotox.2023.100441 · Cited by 3
Ghosh, A., Soundharya, R., Jolly, M. K., & Majumder, A. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.10.22.619405 · Cited by 2
Jang, J., & Yang, S. (2025) · Organoid · doi:10.51335/organoid.2025.5.e8 · Cited by 1
“In summary, the convergence of lung organoid-based organ-on-a-chip and bioprinting technologies is enhancing the realism of human lung tissue simulation and its application to modeling diverse pulmonary diseases and drug discovery [3,78,79].”
Targeting Tumor‐Immune Microenvironment with Organoid and Organ‐on‐a‐Chip: An Updated Review
Madani, S., Holman, J. B., Rajput, M. U., Ali, S. W., Shi, Z., Qiu, B., Zhang, A., Li, C., & Ding, W. (2025) · Advanced Materials Technologies · doi:10.1002/admt.202501704 · Cited by 1
Chen, Y., Xu, N. L. J., Dong, M., Liu, W., Liu, Z., Sun, G., & Jia, Y. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1773734 · Cited by 2
“Similarity, micro fl uidic organ-on-a-chip platforms allow fl uid fl ow to mimic perfusion, and partially compensating for the lack of vascularization (49).”
Recent Advances of Hydrogels in 3D Cell Culture: A New Dimension in Biomedical Research
Naga, A., Bera, S., & Kundu, M. (2026) · Polymers for Advanced Technologies · doi:10.1002/pat.70645 · Cited by 1
Adipose Tissue Resident Stem Cells
Baptista, L. S. (2023) · Elsevier eBooks · doi:10.1016/b978-0-443-15289-4.00008-1 · Cited by 1
Gastric organoids: Rise of a latecomer
Yang, J.-C., Zhang, Y.-H., & Hu, B. (2024) · World Chinese Journal of Digestology · doi:10.11569/wcjd.v32.i3.182
Optimizing Oncology Tools: Organ-On-A-Clip Alternative to Animal Model
Manwatkar, S., Puri, M. V., Gondhale-Karpe, P., Mahajan, B., Kumar, B., & Kulkarni, S. (2024) · Springer eBooks · doi:10.1007/978-981-97-2596-0_8
Prostate cancer: Current status and preclinical research
Karmakar, A., & Kumar, L. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-31656-2.00001-3
Revolutionizing cancer care: Bioprinting prostate cancer stem cells for targeted treatments
Gharia, J., Pimplaskar, S., & Prajapati, A. (2025) · World Journal of Clinical Oncology · doi:10.5306/wjco.v16.i7.107007
Madden, J. C., Enoch, S. J., Paini, A., & Cronin, M. (2026) · Alternatives to Laboratory Animals · doi:10.1177/02611929261423850 · Cited by 1
Ghosh, A., Ramu, S., Jolly, M. K., & Majumder, A. (2026) · Macromolecular Bioscience · doi:10.1002/mabi.202500636
“In recent times, 3D cell culture systems have emerged as a better approach to mimic in vivo conditions, capturing cell-cell interactions and tissue architecture [ 38–45 ].”
Ma, Y.-X., Li, J.-B., Wei, C.-Y., Zhang, Z.-Y., Gao, Y.-H., Zhou, Y., Ma, X.-M., & Ji, W. (2026) · Microchemical journal (Print) · doi:10.1016/j.microc.2026.118401
Tooth-on-a-chip models: Advances in simulating dental pulp and dentin physiology
Jafari, N., Nejati, O., Darbouy, M., Derakhshani, A., Madani, G., Nejati, A., Zarepour, A., Khosravi, A., & Zarrabi, A. (2026) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2026.118927
Global burden-integrated analysis of osteoarthritis research-to-translation dynamics, 1999–2023
Mukherjee, R., & Chang, C.-M. (2026) · PLoS ONE · doi:10.1371/journal.pone.0349128
“The authors have declared that no competing interests exist. vitro, ex vivo, and microphysiological systems), and funding acknowledgement coverage derived from publication meta-data [9,10].”
Converging bioengineering technologies toward predictive, human-relevant in vitro tissue models
Özgün, A., St‐Pierre, J., Fraiz, E. M., & Variola, F. (2026) · In vitro models · doi:10.1007/s44164-026-00131-z · Cited by 1
“In the past few years, in vitro bioengineering has transitioned from working on individual technologies [ 1 ] to combining them in creative ways [ 2 ].”
New insights in tumor-on-a-chip models for studying cancer drug resistance
Wang, Y., Shi, L., Li, J., Zhang, X., Ren, J., Jia, Q., Lv, L., Yang, L., Zhang, Z., Yang, J., et al. (2026) · Pathology - Research and Practice · doi:10.1016/j.prp.2026.156562
Dandekar, P. P., Jain, R., Parvatam, S., & Mehta, V. (2026) · NAM journal. · doi:10.1016/j.namjnl.2026.100116
The chemokine network in lupus nephritis: pathogenesis, targeted therapies, and future directions
Wang, C., & Chen, L. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1867426
Dhal, A., Aviña, A. E., Peng, P.-W., & Yang, T. (2026) · ACS Applied Engineering Materials · doi:10.1021/acsaenm.6c00402
Warda, M., Ömür, A. D., Park, H.-J., Bae, J.-W., & El‐Aty, A. M. A. (2026) · Bioengineering · doi:10.3390/bioengineering13090976
“To achieve these objectives, modern reproductive microphysiological systems increasingly combine advanced biomaterials with microfluidic engineering [78,79].”
Current and emerging new approach & methodologies for skin hazard assessment
Shin, S.-Y., & Lim, K. (2026) · Toxicological Research · doi:10.1007/s43188-026-00374-8
Xiu, L., Zhang, J., Bong, W., Jeong, S., Yue, T., Hann, S.-Y., Wang, Y., Cui, H., & Zhang, L. G. (2026) · Small · doi:10.1002/smll.76030
Microphysiological systems for screening environmental toxins and pollutants
Flynn, G., & Truskey, G. A. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-16110-0.00032-7
Future perspective for design and development of body-on-a-chip devices
He, H., & Ruder, W. C. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-16110-0.00017-0 · Cited by 1
Metadata
- Authors
- Baptista, L. S., Porrini, C., Kronemberger, G. S., Kelly, D. J., & Perrault, C. M.
- Affiliations
- Universidade Federal do Rio de Janeiro (BR)
- Trinity College Dublin (IE)
- Royal College of Surgeons in Ireland (IE)
- Corresponding author
- Porrini, Constance
- Venue
- Frontiers in Cell and Developmental Biology
- Publisher
- Frontiers Media SA
- Published
- 2022-11-21
- Volume
- 10
- Pages
- 1043117-1043117
- ISSN
- 2296-634X (ISSN-L)
- PMC
- PMC9720174
- OpenAlex
- W4309740738
- Semantic Scholar
- 40a124d32fbb2a39a90bd951972e16bd4d47c56d
- Cited by
- 90
- References
- 106
- Citations by year
- 2026: 22 · 2025: 31 · 2024: 22 · 2023: 15
- FWCI
- 1.51
- Type
- journal article
- Language
- en
- Update notices
- corrigendum (2024-01-26)
- Open access
- gold
- doi.org
- Licence
- Locations
- Frontiers in Cell and Developmental Biology (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Greater South Information System
- Funders
- H2020 Marie Skłodowska-Curie Actions
- Topics
- Physical Sciences › Engineering › Biomedical Engineering › 3D Printing in Biomedical Research
- Physical Sciences › Engineering › Biomedical Engineering › Microfluidic and Capillary Electrophoresis Applications
- Health Sciences › Medicine › Surgery › Tissue Engineering and Regenerative Medicine
- Keywords
- organ-on-a-chip, organoids, microphysiological systems, microfluidics, 3D cell culture, drug discovery, drug development, bioprinting, stem cell-derived models, reproducibility
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.